3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Head and Neck Neoplasms
1
Interventions
Iodine-131
3
Thyrotropin Alfa
2
vandetanib
1
lenvatinib
1
fosbretabulin
1
combretastatin
1
cabozantinib
1
Thyroidectomy
1
Sorafenib
1
Ropivacaine
1
Radiotherapy
1
Paclitaxel
1
Neck Dissection
1
Metformin
1
Epinephrine
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Thyroid Neoplasms
×
fosbretabulin
×
Clear all
NCT01701349
2014-05-01
FACT2
Mateon Therapeutics
Phase 3
Withdrawn